In many therapy sessions, the issue that brings a client into treatment is not always the issue that most affects their well-being.
Clients may initially seek help for anxiety, depression, stress, or relationship difficulties. Yet over time, therapists sometimes discover that substance use plays a meaningful role in the client’s struggles.
This does not necessarily mean severe addiction. In many cases, it involves patterns of drug use that gradually begin to influence mood, decision-making, relationships, or functioning.
Because these patterns can be difficult to recognize through conversation alone, structured screening tools can provide valuable insight. One commonly used measure that helps clinicians identify potential concerns is the Drug Abuse Screening Test – 10 (DAST-10).
Drug use exists along a spectrum. Some individuals experiment occasionally without significant consequences, while others experience increasing difficulty controlling their use or managing the impact on daily life.
In clinical practice, the challenge is often identifying where a client falls on that spectrum.
The DAST-10 helps therapists explore patterns related to:
- difficulty controlling drug use
- consequences affecting work or daily responsibilities
- strain in relationships or social functioning
- concerns raised by family members or friends
- attempts to reduce or stop using substances
Rather than focusing on a specific drug, the measure looks at the effects that drug use may be having on a person’s life. This broader approach makes it applicable in a wide range of therapeutic contexts.
Discussing substance use can be uncomfortable for many clients. Feelings of shame, fear of judgment, or uncertainty about how their behavior will be interpreted may prevent open conversations.
Structured screening tools can help ease this challenge.
When a therapist introduces a brief questionnaire as part of a standard assessment process, the conversation shifts away from personal judgment and toward shared exploration.
Clients may find it easier to answer structured questions than to initiate discussions about substance use on their own. As a result, screening tools often reveal patterns that might otherwise remain hidden.
This information can help therapists develop a more complete understanding of the client’s overall situation.
Substance use patterns may change throughout therapy. Some clients begin reducing their use as emotional distress improves, while others may experience periods of increased vulnerability or relapse.
When a screening tool like the DAST-10 is administered periodically, therapists can observe patterns such as:
- gradual reduction in risk behaviors
- temporary increases during stressful life events
- stable patterns that may require additional intervention
- early warning signs that suggest relapse risk
Monitoring these patterns over time helps therapists respond more proactively rather than reacting only when a crisis emerges.
For many clients, seeing measurable progress can also strengthen motivation to continue making changes.
Substance use rarely exists in isolation. It often interacts with other aspects of mental health, including mood disorders, trauma responses, or relationship challenges.
Because of this, screening tools for substance use are frequently used alongside other assessments that examine emotional well-being or psychological distress.
When therapists consider these measures together, they can better understand how different aspects of a client’s experience may be connected.
For example:
- substance use may increase during periods of anxiety
- depression may worsen after heavy drug use
- avoidance behaviors may reinforce both anxiety and substance use
Recognizing these patterns helps guide more comprehensive treatment planning.
In measurement-based clinical practice, structured tools are most effective when they can be administered and interpreted efficiently.
Within MyOutcomes®, therapists can incorporate screening tools such as the DAST-10 into a digital workflow designed to support ongoing outcome monitoring.
The platform allows clinicians to:
- send assessments electronically to clients
- receive automatically scored results
- observe patterns across multiple sessions
- compare substance use trends alongside other outcome indicators
- generate clear visual reports for clinical review
Having these insights available in one place helps clinicians maintain a broader perspective on how treatment is progressing.
Substance use concerns are often easier to address when they are identified early. Screening tools provide clinicians with a structured method for recognizing potential risk before problems escalate.
The DAST-10 offers therapists a concise way to explore whether drug use may be contributing to a client’s challenges and whether additional attention or support might be beneficial.
When used thoughtfully, tools like this help clinicians move beyond assumptions and rely instead on clear, structured information.
Like all clinical measures, screening tools are most helpful when interpreted within the broader context of a client’s life.
Therapists should consider factors such as:
- cultural and social influences
- environmental stressors
- access to support systems
- co-occurring mental health concerns
Screening scores are not labels or diagnoses. Instead, they serve as starting points for conversation and clinical exploration.
Approaching results with empathy and collaboration can help clients feel supported rather than judged.
Therapy often involves uncovering patterns that were not immediately visible at the beginning of treatment. Structured screening tools can play an important role in this discovery process.
By helping clinicians recognize how substance use may interact with emotional well-being and daily functioning, tools like the DAST-10 contribute to more thoughtful and responsive care.
When integrated into a feedback-informed system such as MyOutcomes®, these insights become part of a larger picture that helps therapists track progress, adjust treatment, and support long-term change.
Skinner, H. A. (1982).
The Drug Abuse Screening Test. Addictive Behaviors, 7(4), 363–371.
Skinner, H., Samadi, S., Khan, S. B., & Crowley, L. (2024).
The Drug Abuse Screening Test (DAST): First 40 Years and Future Developments.
The Canadian Journal of Addiction, 15(4), 6–13.
Yudko, E., Lozhkina, O., & Fouts, A. (2007).
A comprehensive review of the psychometric properties of the DAST.
Journal of Substance Abuse Treatment, 32(2), 189–198.
